Do Genetic Variants of the Renin-Angiotensin System Predict Blood Pressure Response to Renin-Angiotensin System–Blocking Drugs? A Systematic Review of Pharmacogenomics in the Renin-Angiotensin System

A new-generation N/L-type calcium channel blocker leads to less activation of the renin–angiotensin system compared with conventional L type calcium channel blocker

(2010) Tadashi Konoshita et al.   JOURNAL OF HYPERTENSION

Effect of ACE insertion/deletion and 12 other polymorphisms on clinical outcomes and response to treatment in the life study

(2010) Børge G. Nordestgaard et al.   Pharmacogenetics and Genomics

Genetic Variant of the Renin-Angiotensin System and Diabetes Influences Blood Pressure Response to Angiotensin Receptor Blockers

(2009) T. Konoshita et al.   DIABETES CARE

Adenine/cytosine1166 polymorphism of the angiotensin II type 1 receptor gene and the antihypertensive response to angiotensin-converting enzyme inhibitors

(2009) Huimin Yu et al.   JOURNAL OF HYPERTENSION

ACE Gene Polymorphism and Losartan Treatment in Type 2 Diabetic Patients With Nephropathy

(2008) H.-H. Parving et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Clinical variables, not RAAS polymorphisms, predict blood pressure response to ACE inhibitors in Sardinians

(2008) Fabiana Filigheddu et al.   PHARMACOGENOMICS